261 related articles for article (PubMed ID: 30099447)
21. Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival.
Moshaver B; van der Pol MA; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Leuk Lymphoma; 2008 Jan; 49(1):134-48. PubMed ID: 17926185
[TBL] [Abstract][Full Text] [Related]
22. IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.
Chapuis N; Park S; Leotoing L; Tamburini J; Verdier F; Bardet V; Green AS; Willems L; Agou F; Ifrah N; Dreyfus F; Bismuth G; Baud V; Lacombe C; Mayeux P; Bouscary D
Blood; 2010 Nov; 116(20):4240-50. PubMed ID: 20671123
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.
Del Poeta G; Bruno A; Del Principe MI; Venditti A; Maurillo L; Buccisano F; Stasi R; Neri B; Luciano F; Siniscalchi A; de Fabritiis P; Amadori S
Curr Cancer Drug Targets; 2008 May; 8(3):207-22. PubMed ID: 18473734
[TBL] [Abstract][Full Text] [Related]
24. Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis.
Qiu Y; Bai L; Zhao H; Mei X
BMC Cancer; 2024 Apr; 24(1):520. PubMed ID: 38658865
[TBL] [Abstract][Full Text] [Related]
25. Survival of acute myeloid leukemia cells requires PI3 kinase activation.
Xu Q; Simpson SE; Scialla TJ; Bagg A; Carroll M
Blood; 2003 Aug; 102(3):972-80. PubMed ID: 12702506
[TBL] [Abstract][Full Text] [Related]
26. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.
Song JH; Kim SH; Kweon SH; Lee TH; Kim HJ; Kim HJ; Kim TS
Int J Oncol; 2009 Apr; 34(4):1165-71. PubMed ID: 19287976
[TBL] [Abstract][Full Text] [Related]
27. Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.
Fiskus W; Rao R; Fernandez P; Herger B; Yang Y; Chen J; Kolhe R; Mandawat A; Wang Y; Joshi R; Eaton K; Lee P; Atadja P; Peiper S; Bhalla K
Blood; 2008 Oct; 112(7):2896-905. PubMed ID: 18660379
[TBL] [Abstract][Full Text] [Related]
28. Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
Zhang X; Yang L; Liu X; Nie Z; Liu M; Wang T; Lu Y; Pan Y; Zhan Y; Wang Z; Luo J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119607. PubMed ID: 37852323
[TBL] [Abstract][Full Text] [Related]
29. Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.
Qu X; Li Y; Liu J; Xu L; Zhang Y; Hu X; Hou K; Liu Y
Mol Cell Biochem; 2010 Jul; 340(1-2):107-14. PubMed ID: 20177738
[TBL] [Abstract][Full Text] [Related]
30. DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia.
Sun H; Ren Y; Zhou X; Chen Q; Liu Y; Zhu C; Ruan Y; Ruan H; Tong H; Ying S; Lin P
Technol Cancer Res Treat; 2023; 22():15330338231207765. PubMed ID: 37872685
[No Abstract] [Full Text] [Related]
31. 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.
Ray S; Ponnathpur V; Huang Y; Tang C; Mahoney ME; Ibrado AM; Bullock G; Bhalla K
Cancer Chemother Pharmacol; 1994; 34(5):365-71. PubMed ID: 7915211
[TBL] [Abstract][Full Text] [Related]
32. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
Garrido SM; Appelbaum FR; Willman CL; Banker DE
Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine.
Tabe Y; Saitoh K; Yang H; Sekihara K; Yamatani K; Ruvolo V; Taka H; Kaga N; Kikkawa M; Arai H; Miida T; Andreeff M; Spagnuolo PA; Konopleva M
Sci Rep; 2018 Nov; 8(1):16837. PubMed ID: 30442990
[TBL] [Abstract][Full Text] [Related]
34. CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway.
Tang S; Li S; Shi X; Sheng L; Mu Q; Wang Y; Zhu H; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Anticancer Drugs; 2024 Feb; 35(2):163-176. PubMed ID: 37948318
[TBL] [Abstract][Full Text] [Related]
35. Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia.
Zhang B; Deng X; You R; Liu J; Hou D; Wang X; Chen S; Li D; Fu Q; Zhang J; Huang H; Chen X
Neoplasia; 2024 Jan; 47():100952. PubMed ID: 38159363
[TBL] [Abstract][Full Text] [Related]
36. Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo.
Gao N; Budhraja A; Cheng S; Liu EH; Huang C; Chen J; Yang Z; Chen D; Zhang Z; Shi X
Apoptosis; 2011 May; 16(5):511-23. PubMed ID: 21336837
[TBL] [Abstract][Full Text] [Related]
37. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.
Park S; Chapuis N; Tamburini J; Bardet V; Cornillet-Lefebvre P; Willems L; Green A; Mayeux P; Lacombe C; Bouscary D
Haematologica; 2010 May; 95(5):819-28. PubMed ID: 19951971
[TBL] [Abstract][Full Text] [Related]
38. Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.
Carneiro BA; Kaplan JB; Altman JK; Giles FJ; Platanias LC
Cancer Biol Ther; 2015; 16(5):648-56. PubMed ID: 25801978
[TBL] [Abstract][Full Text] [Related]
39. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins.
Konopleva M; Tari AM; Estrov Z; Harris D; Xie Z; Zhao S; López-Berestein G; Andreeff M
Blood; 2000 Jun; 95(12):3929-38. PubMed ID: 10845930
[TBL] [Abstract][Full Text] [Related]
40. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia.
Gaur T; Ali A; Sharma D; Gupta SK; Gota V; Bagal B; Platzbeckar U; Mishra R; Dutt A; Khattry N; Mills K; Hassan MI; Sandur S; Hasan SK
Cell Signal; 2024 Feb; 114():111004. PubMed ID: 38048856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
